Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Cancer Chemotherapy and Pharmacology
|
March 20, 2019
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
BMC Cancer
|
July 28, 2023
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, et al.
Journal for Immunotherapy of Cancer
|
March 10, 2021
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Davide Melisi, Do-Youn Oh, Antoine Hollebecque, et al.
Journal of Thrombosis and Thrombolysis
|
November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes
Jessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
Journal of the American Heart Association
|
August 27, 2016
Discovery and Clinical Evaluation of MK-8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release
Clayton D Knox, Pieter-Jan de Kam, Karim Azer, et al.
The Journal of Organic Chemistry
|
January 2, 2025
Highly Diastereoselective Access to Densely Functionalized Piperidine Cores of Influenza Endonuclease Inhibitors via a Metal-Free S<sub>N</sub>1 Approach
Yonglian Zhang, Chunrui Sun, Liangqin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
Timothy A Yap, Maria Vieito, Capucine Baldini, et al.
Journal of Medicinal Chemistry
|
February 27, 2020
Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases
Ling Tong, Wenping Li, Michael Man-Chu Lo, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Cancer Chemotherapy and Pharmacology
|
March 20, 2019
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
BMC Cancer
|
July 28, 2023
A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
Ernest Nadal, Mansoor Saleh, Santiago Ponce Aix, et al.
Journal for Immunotherapy of Cancer
|
March 10, 2021
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Davide Melisi, Do-Youn Oh, Antoine Hollebecque, et al.
Journal of Thrombosis and Thrombolysis
|
November 18, 2015
PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes
Jessica L Mega, Sandra L Close, Stephen D Wiviott, et al.
Journal of the American Heart Association
|
August 27, 2016
Discovery and Clinical Evaluation of MK-8150, A Novel Nitric Oxide Donor With a Unique Mechanism of Nitric Oxide Release
Clayton D Knox, Pieter-Jan de Kam, Karim Azer, et al.
The Journal of Organic Chemistry
|
January 2, 2025
Highly Diastereoselective Access to Densely Functionalized Piperidine Cores of Influenza Endonuclease Inhibitors via a Metal-Free S<sub>N</sub>1 Approach
Yonglian Zhang, Chunrui Sun, Liangqin Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 22, 2021
First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer
Timothy A Yap, Maria Vieito, Capucine Baldini, et al.
Journal of Medicinal Chemistry
|
February 27, 2020
Discovery of [<sup>11</sup>C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases
Ling Tong, Wenping Li, Michael Man-Chu Lo, et al.
Page
of 3